ArticleJournal for immunotherapy of cancer2020

Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells.

Heyu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.